Cost-effectiveness of extended release naltrexone to prevent relapse among criminal justice-involved individuals with a history of opioid use disorder.

Background and Aims Criminal justice-involved individuals are highly susceptible to opioid relapse and overdose-related deaths. In a recent randomized trial, we demonstrated the effectiveness of extended-release naltrexone (XR-NTX; Vivitrol®) in preventing opioid relapse among criminal justice-invol...

Descripción completa

Detalles Bibliográficos

Publicado en:	Addiction Vol. 112; no. 8; pp. 1440 - 1451
Autores principales:	Murphy, Sean M., Polsky, Daniel, Lee, Joshua D., Friedmann, Peter D., Kinlock, Timothy W., Nunes, Edward V., Bonnie, Richard J., Gordon, Michael, Chen, Donna T., Boney, Tamara Y., O'Brien, Charles P.
Formato:	research tables/charts randomized controlled trial Journal Article
Publicado:	Wiley-Blackwell Aug2017
Acceso en línea:	Ver este registro en EBSCOhost